Search results
Results from the WOW.Com Content Network
In bacterial cells, ribosomes are synthesized in the cytoplasm through the transcription of multiple ribosome gene operons. In eukaryotes, the process takes place both in the cell cytoplasm and in the nucleolus, which is a region within the cell nucleus. The assembly process involves the coordinated function of over 200 proteins in the ...
Prokaryotic ribosomes begin translation of the mRNA transcript while DNA is still being transcribed. Thus translation and transcription are parallel processes. Bacterial mRNA are usually polycistronic and contain multiple ribosome binding sites. Translation initiation is the most highly regulated step of protein synthesis in prokaryotes.
Ribosomal RNA is the predominant form of RNA found in most cells; it makes up about 80% of cellular RNA despite never being translated into proteins itself. Ribosomes are composed of approximately 60% rRNA and 40% ribosomal proteins, though this ratio differs between prokaryotes and eukaryotes. [2] [3]
Ribosomes: The ribosome is a large complex of RNA and protein molecules. [2] ... A gelatinous capsule is present in some bacteria outside the cell membrane and cell wall.
The bacterial cell wall differs from that of all other organisms by the presence of peptidoglycan which is located immediately outside of the cell membrane. Peptidoglycan is made up of a polysaccharide backbone consisting of alternating N-Acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) residues in equal amounts.
Prokaryotic ribosomes have a different structure from that of eukaryotic ribosomes, and thus antibiotics can specifically target bacterial infections without harming a eukaryotic host's cells. Basic mechanisms
A third protein that can bind to ribosomes when E. coli cells enter the stationary phase is YfiA (previously known as RaiA). [22] HPF and YfiA are structurally similar, and both proteins can bind to the catalytic A- and P-sites of the ribosome. [23] [24] RMF blocks ribosome binding to mRNA by preventing interaction of the messenger with 16S ...
The structural characterization of the eukaryotic ribosome [16] [17] [24] may enable the use of structure-based methods for the design of novel antibacterials, wherein differences between the eukaryotic and bacterial ribosomes can be exploited to improve the selectivity of drugs and therefore reduce adverse effects.